New research suggests peanut allergy cure may be possible

A new treatment for peanut allergies has been shown to offer long-lasting effects in a study conducted by the Murdoch Children's Research Institute.

The Australian study assessed a novel oral immunotherapy, combining the probiotic Lactobacillus rhamnosus and peanut proteins, with allergic children fed increasing amounts of this mixture over time to see if they developed a tolerance.

At the end of the original trial in 2013, 82 percent of children who received the immunotherapy were deemed tolerant to peanuts. Four years later, 80 percent of children who gained initial tolerance were shown to still eating peanuts as part of their normal diet, with 70 percent passing a further test confirming long-term tolerance.

Professor Mimi Tang at the Murdoch Children's Research Institute said: "These findings suggest our treatment is effective at inducing long-term tolerance, up to four years after completing treatment, and is safe."

The results also indicate that tolerance is a realistic target for treating food allergy, even among individuals who would otherwise experience potentially fatal reactions to certain foods.

With over 20 years of experience within the science market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current science roles we have available, you can search for the latest job roles, register your details, or contact the team today.